» BrainCool receives new US order and secures loan
» Alligator Bioscience is ready for an exciting news flow
» Saniona ready to advance its Q7 program
» Cyxone comments on scientific T20K article
» WntResearch on the new clinical findings
Read BioStock's newsletter for v.33 here.
Morning news
Chordate Medical begins market introduction of migraine treatment in Israel. Read more.
The subscription price for Lumitos warrants of series TO4 set at SEK 0,93 per share. Read more.
Robust health economic evaluation presented by Implantica. Read more.
Amniotic phase I/II study with PulmoStem is ready to start. Read more.
holistic launches two new tests for respiratory infections. Read more.
Staffan Skogvall CEO of PharmaLundensis increases its holdings. Read more.
Navigation robot increases patient safety during spinal surgeries Norrland University Hospital in Umeå. Read more.
Company reports:
Elicera Therapeutics S2Medical (Correction)
Upcoming report releases:
Acarix Marking DannCann Pharma Nykode Therapeutics
Share transactions and changes in equity:
Inify Laboratories
News since Friday lunch
Board member Anders Mansson leaves Amniotic, the company announces. Read more.
CS Medica in dialogue with European veterinary company regarding the company's medical CBD products. Read more.
On August 24th, iZafe a live interview regarding the acquisition of Pillox. Read more.
Pharmivas new CEO Anna Linton will present the company on Thursday, August 25. Read more.
Guard Therapeutics has invited to Capital Markets Day on September 21st. Read more.
This morning's price development
Winner: Chordate Medical 15,5%, Medimi 8,4%, Scandinavian ChemoTech 7,9%, Vivesto 7,9%, Implantica 5,8%
Förlorare: Lumito -8,5%, Calmark -11,3%, Active Biotech -8,9%, Oncopeptides -7,3%, Gabather -6,9%
Index: OMXS30 2007 -1,49%, Healthcare -0,47%